DEF: Abrdn Healthcare Funds Announce Annual Shareholder Meetings to Elect Trustees

Abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund will hold annual shareholder meetings on May 28, 2025, to elect trustees.

Summary

• Abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund will hold their annual shareholder meetings on May 28, 2025, at 12:30 p.m. Eastern Time.
• The meetings will take place at the offices of abrdn Inc. in Philadelphia.
• Shareholders of record as of April 7, 2025, are entitled to vote.
• The primary purpose of the meetings is to elect trustees to serve until the 2028 Annual Meeting.
• For HQH and HQL, shareholders will elect two Class C Trustees.
• For THQ, shareholders will elect two Class B Trustees.
• For THW, shareholders will elect two Class A Trustees.
• The Board of Trustees recommends voting 'FOR' each nominee.
• Shareholders can vote by mail, telephone, or internet.
• The proxy materials are available online.
• EQ Fund Solutions, LLC has been retained to assist in the solicitation of proxies and will receive an estimated fee of $2,500 per Fund and be reimbursed for its reasonable expenses, which are estimated to be $825-$1,350 for each Fund.
• As of the record date, the number of outstanding shares for each fund were: HQH 53,862,184.0, HQL 28,872,416.0, THQ 41,379,166.7, and THW 39,849,957.6.

Sentiment

Score: 7

Explanation: The document is neutral in tone, focusing on procedural matters related to the annual meetings and trustee elections. The information is presented clearly and professionally, indicating a stable and well-managed fund structure.

Positives

• The document provides clear instructions on how shareholders can vote.
• The Board of Trustees is providing recommendations on how to vote.
• The proxy materials are readily available online.
• The document details the qualifications and experience of the trustee nominees.
• The document provides transparency regarding the fees paid to EQ Fund Solutions, LLC for proxy solicitation.

Negatives

• The document primarily focuses on procedural matters related to the annual meetings and trustee elections, lacking insights into the funds' performance or future strategies.
• A late Form 4 filing was submitted for Alan Goodson, an officer of the Fund, with respect to an open-market purchase of HQH shares.
• Due to an administrative oversight of the Adviser, a Form 4 filing was submitted one day late for Kathleen Goetz, a Trustee of the Fund, with respect to the open-market purchase of HQH, HQL, THQ and THW shares.

Risks

• Failure to achieve quorum at the meetings could delay the election of trustees.
• Shareholder dissatisfaction with the nominees could lead to contested elections.
• Administrative oversights, such as the late filing of Form 4, could raise concerns about compliance and internal controls.
• Dependence on third-party proxy solicitation services like EQ Fund Solutions introduces operational risk.

Future Outlook

The document does not contain specific forward-looking statements regarding the funds' financial performance or investment strategies beyond the election of trustees.

Management Comments

• Each Board believes that each Trustee's experience, qualifications, attributes and skills on an individual basis and in combination with those of other Trustees lead to the conclusion that each Trustee should serve in such capacity.
• The Board of each Fund has determined that its leadership structure is appropriate for the Fund because it enables the Board to exercise informed and independent judgment over matters under its purview, allocates responsibility among committees in a manner that fosters effective oversight and allows the Board to devote appropriate resources to specific issues in a flexible manner as they arise.

Industry Context

The document reflects standard corporate governance practices for closed-end investment funds, including the election of trustees and the establishment of board committees to oversee fund operations and risk management. The involvement of abrdn Inc. as the investment advisor and administrator aligns with common industry structures.

Comparison to Industry Standards

• The structure of the Board of Trustees, with a majority of independent trustees, aligns with industry best practices and regulatory requirements for registered investment companies.
• The establishment of Audit, Nominating and Corporate Governance, and Private Venture Valuation Committees is consistent with standard governance structures observed in similar funds.
• The disclosure of fees paid to the independent registered public accounting firm (KPMG) and the proxy solicitation firm (EQ Fund Solutions) is in line with regulatory requirements and promotes transparency.
• The process for shareholder proposals and the exercise of discretionary voting authority adhere to SEC rules and regulations.

Management Changes

Stakeholder Impact

• Shareholders have the opportunity to vote on the election of trustees, influencing the governance and oversight of the funds.
• The election of qualified trustees is intended to benefit shareholders by ensuring effective management and protection of their investments.
• The disclosure of fees and expenses provides transparency to shareholders regarding the costs associated with fund operations.

Next Steps

• Shareholders should review the proxy materials and vote on the proposals.
• The Annual Meetings will be held on May 28, 2025, to elect the trustees.
• The newly elected trustees will serve until the 2028 Annual Meeting.
• The Board will continue to oversee the management and operations of the funds.

Key Dates

Keywords

trustees, proxy statement, annual meeting, shareholders, abrdn, healthcare funds, election